News
HMS Is Facing a Deficit. Under Trump, Some Fear It May Get Worse.
News
Cambridge Police Respond to Three Armed Robberies Over Holiday Weekend
News
What’s Next for Harvard’s Legacy of Slavery Initiative?
News
MassDOT Adds Unpopular Train Layover to Allston I-90 Project in Sudden Reversal
News
Denied Winter Campus Housing, International Students Scramble to Find Alternative Options
Med Student Expelled
Harvard Medical School has expelled a student who admitted he fabricated research evidence.
Mitchell Rosner, who completed three years of Harvard Medical School, has been required to with draw from the school, period," associate Dean Suzanne Rauffenbart said yesterday.
Rauffenbart said a Medical School committee had reviewed the case. The Committee recommended the punishment to Dean Daniel C. Tosteson '44, who then notified Rosner is a letter last Friday, Rauffenbart said. The research in question, which asserted that a certain protein was necessary for cell division, was published in the March 1991 issue of Cell.
It was done while Rosner was working at the National Institute of Health. In May 1992, the scientific journal published an apology and retraction stating that Rosner had fabricated the research.
Rosner's attorney, Steven Hansen, could not be reached for comment yesterday. IES
Vika to Perform
The Ukrainian rock group, Vika, will be performing at the Longy school of Music today in concert sponsored by the Harvard Ukrainian summer Institute.
The group, headed by singer Vika Vradij, who was recently chosen as "Miss Rock of Europe--92" is known for "progressive" "postpunk" politically charged songs and interpretations s of Ukrainan folk music.
Named by Soviet officials as "a destructive element," Vika had been banned from Ukrainian television for years, said Yuri Shevchuk, an instructor of Ukrainian at the summer school.
With the coming of perestroika the band was allowed more exposure in the Ukraine. The group gained national attention at the Chervona Ruta Festival in 1989. JS
Want to keep up with breaking news? Subscribe to our email newsletter.